Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Sixfold Bioscience
Sixfold Bio is revolutionizing RNA therapies by addressing the critical challenge of RNA delivery. Their platform, inspired by nature and powered by AI, utilizes a proprietary programmable RNA tag…
Sixfold Bioscience
Sixfold Bio is revolutionizing RNA therapies by addressing the critical challenge of RNA delivery. Their platform, inspired by nature and powered by AI, utilizes a proprietary programmable RNA tag…
TL;DR
Founded: 2017
Headquarters: White City, London
Focus: AI-enabled programmable RNA delivery platform (Mergo®) for siRNA and mRNA
Stage: Preclinical
Seed funding (announced): $10.5M USD total (seed round reported)
Company Overview
Problem Domain
RNA therapeutics delivery—targeting specific cell types beyond liver for siRNA and mRNA medicines.
Founded
2017
Industry
Biotechnology
Funding Track Record
$10.5M USD (seed financing reported, including a second close)
Company reported a $10.5M USD seed financing (second close raised $2.2M USD).
Grant funding activity reported on Dec 2, 2021; company has also received public/non-dilutive funding (Innovate UK, European Commission).
Awarded Biomedical Catalyst funding from Innovate UK (~£0.89M / just over $1M) to support Mergo® development.
Investor Signal
“Venture and public funders including Y Combinator, Cantos Ventures, Lombard Street Ventures, Pi Campus, Bossa Invest, Innovate UK and the European Commission”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week